A detailed history of Avalon Investment & Advisory transactions in Zoetis Inc. stock. As of the latest transaction made, Avalon Investment & Advisory holds 2,837 shares of ZTS stock, worth $502,035. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,837
Holding current value
$502,035
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $412,726 - $496,531
2,837 New
2,837 $472,000
Q2 2022

Aug 10, 2022

SELL
$155.97 - $200.09 $5,302 - $6,803
-34 Reduced 2.19%
1,519 $261,000
Q1 2022

May 17, 2022

BUY
$181.39 - $234.03 $281,698 - $363,448
1,553 New
1,553 $293,000
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $326,755 - $416,739
-1,687 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$189.29 - $209.69 $319,332 - $353,747
1,687 New
1,687 $328,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Avalon Investment & Advisory Portfolio

Follow Avalon Investment & Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.